Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)

This publication has 57 references indexed in Scilit:

• Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype
  Thrombosis and Haemostasis, 2005
• Selecting Patients With Atrial Fibrillation for Anticoagulation
  Circulation, 2004
• Combined Anticoagulant–Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients
  Stroke, 2004
• The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon
  Thrombosis and Haemostasis, 2004
• Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial
  The Lancet, 2003
• Kappa coefficients in medical research
  Statistics in Medicine, 2002
• Department of Veterans Affairs Cooperative Studies Program Clinical Trial Comparing Combined Warfarin and Aspirin With Aspirin Alone in Survivors of Acute Myocardial Infarction
  Circulation, 2002
• Adverse Outcomes and Predictors of Underuse of Antithrombotic Therapy in Medicare Beneficiaries With Chronic Atrial Fibrillation
  Stroke, 2000
• Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation
  Stroke, 1999
• Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: A metaanalysis
  American Heart Journal, 1995